UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING


[_] Form 10-K  [_]  Form 20-F  [_]  Form 11-K  [X]  Form 10-QSB  [_]  Form N-SAR

For Period Ended: April 30, 2005

(Check One):

                           [_] Transition Report on Form 10-K
                           [_]  Transition Report on Form 20-F
                           [_] Transition Report on Form 11-K
                           [_] Transition Report on Form 10-Q
                           [_] Transition Report on Form N-SAR

For the Transition Period Ended:
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Read Instruction (on back page) Before Preparing Form.  Please Print or Type.


Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the item(s) to which the notification relates:






                        Part I - Registrant Information


                    Bio Solutions Manufacturing, Inc. (BSLM)
     ----------------------------------------------------------------------
                            Full Name of Registrant

                                       N/A
     ----------------------------------------------------------------------
                           Former Name if Applicable

                                1161 James Street
     ----------------------------------------------------------------------
           Address of Principal Executive Officer (Street and Number)

                              Hattiesburg MS, 39401
     ----------------------------------------------------------------------
                            City, State and Zip Code


                       PART II - RULES 12B-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[X]  a) The  reasons  described  in  reasonable  detail in Part III of this form
     could not be eliminated without unreasonable effort or expense;

[X]  b) The subject annual report, semi-annual report, transition report on Form
     10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof,  will be filed on or
     before the fifteenth calendar day following the prescribed due date; or the
     subject  quarterly  report of  transition  report on Form 10-Q,  or portion
     thereof  will be file on or before the fifth  calendar  day  following  the
     prescribed due date; and

[_]  c) The  accountant's  statement or other exhibit required by Rule 12b-25(c)
     has been attached if applicable.

                               PART III NARRATIVE

State below in  reasonable  detail the reasons  why the Form 10-K,  11-K,  10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period.

Data and other information  regarding certain material operations of the Company
as well as its  financial  statements  required for the filing are not currently
available  and could  not be made  available  without  unreasonable  effort  and
expense.







                           PART IV OTHER INFORMATION


(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification.

       David S. Bennett                (601)            582-4000
     -------------------------      -----------     ------------------------
              (Name)                (Area Code)       (Telephone Number)

(2) Have all other  periodic  reports  required  under Section 13 or 15(d)of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  (or for such  shorter)period  that the
registrant  was  required to file such  reports  been  filed?  (If answer is no,
identify reports).

         [ X ] Yes [_]] No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?

         [_] Yes  [X ] No


                        Bio Solutions Manufacturing, Inc.
     ----------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.


 Date: June 13, 2005                     /s/ David S. Bennett
                                         --------------------------
                                         By: David s. Bennett
                                         Its: Chief Executive Officer